Search

Shanon A. Foley

Examiner (ID: 19153, Phone: (571)272-0898 , Office: P/1648 )

Most Active Art Unit
1648
Art Unit(s)
1619, 1642, 1648, 1671, 1645
Total Applications
1526
Issued Applications
841
Pending Applications
339
Abandoned Applications
367

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16569216 [patent_doc_number] => 20210008222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => PLANT VIRUS PARTICLES FOR DELIVERY OF ANTIMITOTIC AGENTS [patent_app_type] => utility [patent_app_number] => 17/030793 [patent_app_country] => US [patent_app_date] => 2020-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9211 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17030793 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/030793
Plant virus particles for delivery of antimitotic agents Sep 23, 2020 Issued
Array ( [id] => 19338570 [patent_doc_number] => 12048741 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-30 [patent_title] => Recombinant host cell with heterologous nucleic acids encoding SHREK proteins [patent_app_type] => utility [patent_app_number] => 17/031082 [patent_app_country] => US [patent_app_date] => 2020-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 11072 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17031082 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/031082
Recombinant host cell with heterologous nucleic acids encoding SHREK proteins Sep 23, 2020 Issued
Array ( [id] => 17865452 [patent_doc_number] => 20220288187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => BIODEGRADABLE NANOCOMPLEX VACCINES, METHODS FOR SUPPRESSION OF HEPAPITIS B VIRUS REPLICATION AND HEPAPITIS B VIRUS SURFACE ANTIGEN SECRETION [patent_app_type] => utility [patent_app_number] => 17/763184 [patent_app_country] => US [patent_app_date] => 2020-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5271 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763184 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/763184
BIODEGRADABLE NANOCOMPLEX VACCINES, METHODS FOR SUPPRESSION OF HEPAPITIS B VIRUS REPLICATION AND HEPAPITIS B VIRUS SURFACE ANTIGEN SECRETION Sep 22, 2020 Abandoned
Array ( [id] => 19225483 [patent_doc_number] => 12005113 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-11 [patent_title] => Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom [patent_app_type] => utility [patent_app_number] => 17/021261 [patent_app_country] => US [patent_app_date] => 2020-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 198 [patent_figures_cnt] => 236 [patent_no_of_words] => 40575 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021261 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/021261
Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom Sep 14, 2020 Issued
Array ( [id] => 17921628 [patent_doc_number] => 11464849 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-11 [patent_title] => Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof [patent_app_type] => utility [patent_app_number] => 17/017342 [patent_app_country] => US [patent_app_date] => 2020-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 50 [patent_no_of_words] => 40258 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17017342 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/017342
Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof Sep 9, 2020 Issued
Array ( [id] => 16989387 [patent_doc_number] => 20210227807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => METHOD FOR DETECTION AND MITIGATION OF COMPOUND PRODUCING MICROBIOTA IN AN AQUACULTURE SYSTEM [patent_app_type] => utility [patent_app_number] => 16/992760 [patent_app_country] => US [patent_app_date] => 2020-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13289 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16992760 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/992760
METHOD FOR DETECTION AND MITIGATION OF COMPOUND PRODUCING MICROBIOTA IN AN AQUACULTURE SYSTEM Aug 12, 2020 Abandoned
Array ( [id] => 18064479 [patent_doc_number] => 20220395566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-15 [patent_title] => IMMUNOGENIC COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/634272 [patent_app_country] => US [patent_app_date] => 2020-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34956 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634272 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/634272
IMMUNOGENIC COMPOSITION Aug 9, 2020 Abandoned
Array ( [id] => 16915858 [patent_doc_number] => 20210188950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => Antibodies Against F Glycoprotein of Hendra and Nipah Viruses [patent_app_type] => utility [patent_app_number] => 16/988835 [patent_app_country] => US [patent_app_date] => 2020-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16831 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16988835 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/988835
Antibodies against F glycoprotein of Hendra and Nipah viruses Aug 9, 2020 Issued
Array ( [id] => 17836487 [patent_doc_number] => 20220273792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => A METHOD OF ELICITING AN IMMUNE RESPONSE BY ADMINISTERING A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN TOGETHER WITH A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ADJUVANT AS WELL AS COMPOSITIONS COMPRISING THE TWO POPULATIONS OF POLYMERSOMES [patent_app_type] => utility [patent_app_number] => 17/631845 [patent_app_country] => US [patent_app_date] => 2020-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56089 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631845 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/631845
A METHOD OF ELICITING AN IMMUNE RESPONSE BY ADMINISTERING A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN TOGETHER WITH A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ADJUVANT AS WELL AS COMPOSITIONS COMPRISING THE TWO POPULATIONS OF POLYMERSOMES Aug 2, 2020 Pending
Array ( [id] => 16697899 [patent_doc_number] => 10948490 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-03-16 [patent_title] => Severe acute respiratory syndrome (SARS)--associated coronavirus diagnostics [patent_app_type] => utility [patent_app_number] => 16/944649 [patent_app_country] => US [patent_app_date] => 2020-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 11387 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16944649 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/944649
Severe acute respiratory syndrome (SARS)--associated coronavirus diagnostics Jul 30, 2020 Issued
Array ( [id] => 18732575 [patent_doc_number] => 11801295 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-31 [patent_title] => Immunogenic compositions and uses thereof [patent_app_type] => utility [patent_app_number] => 16/941481 [patent_app_country] => US [patent_app_date] => 2020-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 55 [patent_no_of_words] => 31740 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16941481 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/941481
Immunogenic compositions and uses thereof Jul 27, 2020 Issued
Array ( [id] => 17828504 [patent_doc_number] => 20220265808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => A PORCINE CIRCOVIRUS TYPE 2 (PCV2) VACCINE [patent_app_type] => utility [patent_app_number] => 17/628403 [patent_app_country] => US [patent_app_date] => 2020-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14984 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628403 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/628403
A PORCINE CIRCOVIRUS TYPE 2 (PCV2) VACCINE Jul 26, 2020 Abandoned
Array ( [id] => 17355429 [patent_doc_number] => 20220016225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => VACCINE COMPOSITIONS AND ADJUVANT [patent_app_type] => utility [patent_app_number] => 16/933157 [patent_app_country] => US [patent_app_date] => 2020-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9309 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16933157 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/933157
VACCINE COMPOSITIONS AND ADJUVANT Jul 19, 2020 Abandoned
Array ( [id] => 18418586 [patent_doc_number] => 20230173044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => RECOMBINANT PROTEIN FOR REMOVING BOAR TAINT AND VACCINE COMPOSITION COMPRISING THE SAME [patent_app_type] => utility [patent_app_number] => 16/964632 [patent_app_country] => US [patent_app_date] => 2020-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7675 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964632 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/964632
RECOMBINANT PROTEIN FOR REMOVING BOAR TAINT AND VACCINE COMPOSITION COMPRISING THE SAME Jun 28, 2020 Abandoned
Array ( [id] => 17881220 [patent_doc_number] => 20220296697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => PORCINE CIRCOVIRUS TYPE 2 VLP VACCINE [patent_app_type] => utility [patent_app_number] => 17/634488 [patent_app_country] => US [patent_app_date] => 2020-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9901 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634488 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/634488
Porcine circovirus type 2 VLP vaccine Jun 22, 2020 Issued
Array ( [id] => 17297932 [patent_doc_number] => 20210393771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => VIRAL VACCINES FOR IN VIVO EXPRESSION OF A NUCLEIC ACIDS ENCODIND AN IMMUNOGENIC PEPTIDE AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/909311 [patent_app_country] => US [patent_app_date] => 2020-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15603 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16909311 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/909311
Viral vaccines for in vivo expression of a nucleic acid encoding an immunogenic peptide and methods of using the same Jun 22, 2020 Issued
Array ( [id] => 16555719 [patent_doc_number] => 20210000867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => NEW ROUTE AND ENGINEERING PROTOCOLS FOR ALZHEIMERS DISEASE PREVENTION, TREATMENT AND NEURONAL REBUILDING [patent_app_type] => utility [patent_app_number] => 16/906450 [patent_app_country] => US [patent_app_date] => 2020-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10806 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16906450 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/906450
NEW ROUTE AND ENGINEERING PROTOCOLS FOR ALZHEIMERS DISEASE PREVENTION, TREATMENT AND NEURONAL REBUILDING Jun 18, 2020 Abandoned
Array ( [id] => 18700100 [patent_doc_number] => 11786587 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-17 [patent_title] => Composition of subunit dengue vaccine [patent_app_type] => utility [patent_app_number] => 16/906134 [patent_app_country] => US [patent_app_date] => 2020-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 82 [patent_no_of_words] => 14150 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16906134 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/906134
Composition of subunit dengue vaccine Jun 18, 2020 Issued
Array ( [id] => 17775058 [patent_doc_number] => 20220241407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => MINI-COMBINED ADJUVANTS CARRIER-FREE NANOPARTICLES AND REPARATION METHOD AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/256095 [patent_app_country] => US [patent_app_date] => 2020-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2284 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17256095 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/256095
MINI-COMBINED ADJUVANTS CARRIER-FREE NANOPARTICLES AND REPARATION METHOD AND APPLICATION THEREOF Jun 16, 2020 Abandoned
Array ( [id] => 17090919 [patent_doc_number] => 11119103 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-09-14 [patent_title] => Serological assays for SARS-CoV-2 [patent_app_type] => utility [patent_app_number] => 16/900798 [patent_app_country] => US [patent_app_date] => 2020-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15852 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16900798 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/900798
Serological assays for SARS-CoV-2 Jun 11, 2020 Issued
Menu